Exabis Library
Welcome to the e-CCO Library!
OP28 Gene expression (GE) values in a phase 2 trial of mirikizumab in ulcerative colitis (UC) correlate better with histopathology (HP) than endoscopy (EN) and Mayo scores
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP28: A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP28: Children and young adults with inflammatory bowel disease have an increased incidence and risk of developing mental health conditions: a UK population-based cohort study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP28: Host–microbial crosstalk in the pathogenesis of inflammation and cancer in primary sclerosing cholangitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP28: The effect of guselkumab induction therapy on early clinical outcome measures in patients with Moderately to Severely Active Crohn’s Disease: Results from the phase 2 GALAXI 1 study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP29 Tofacitinib in ulcerative colitis: Real-world evidence from Eneida Registry
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP29: Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP29: Peri-natal exposure to parental Crohn's disease is associated with impaired gut barrier, microbiome composition differences and increased risk of Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP29: Peripheral blood DNA methylation biomarkers accurately predict clinical- and endoscopic response to vedolizumab in a real-life cohort of Crohn’s Disease patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP29: ST2+/IL-33 responsive cells promote tumorigenesis in colitis-associated colorectal cancer
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP30 The interplay of microbiome dysbiosis and immune system deregulation in patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP30: Human umbilical cord mesenchymal stem cells derived exosomes alleviate Ulcerative Colitis by inhibiting macrophage ferroptosis via miR-23b-3p/Nrf2 pathway
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP30: Lyophilised orally administered faecal microbiota transplantation for Active Ulcerative Colitis (LOTUS study)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP30: Serum proteomic profiling predicts and diagnoses pouchitis in ulcerative colitis patients undergoing ileal pouch-anal anastomosis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP30: Upadacitinib modulates inflammatory pathways in gut tissue in patients with Ulcerative Colitis: Transcriptomic profiling from the Phase 2b study, U-ACHIEVE
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP31 Meta–omics reveals microbiome-driven proteolysis as a contributing factor to the severity of ulcerative colitis disease activity
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP31: Dietary and Multi-Omic characterization of new onset treatment naive Crohn Disease identifies factors that may contribute to disease pathogenesis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP31: High fat diet exacerbates colitis through microbial metabolite deoxycholic acids induced-ferroptosis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP31: RESTORE: Interim analysis of a Phase 2 study of QBECO SSI for the induction and maintenance of clinical and endoscopic remission in subjects with Moderate to Severe Crohn’s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP31: TP53 mutation in human colonic organoids acquires resistance to in vitro long-term inflammation
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM